Yamamoto K - Search Results

1

β-Hydroxylation of α-amino-β-hydroxylbutanoyl-glycyluridine catalyzed by a nonheme hydroxylase ensures the maturation of caprazamycin.

Zadeh SM, Chen MH, Wang ZC, Astani EK, Lo IW, Lin KH, Hsu NS, Adhikari K, Lyu SY, Tsai HY, Terasawa Y, Yabe M, Yamamoto K, Ichikawa S, Li TL. Zadeh SM, et al. Among authors: yamamoto k. Commun Chem. 2022 Jul 28;5(1):87. doi: 10.1038/s42004-022-00703-6. Commun Chem. 2022. PMID: 36697788 Free PMC article.

2

Total Synthesis of Tunicamycin V.

Yamamoto K, Yakushiji F, Matsumaru T, Ichikawa S. Yamamoto K, et al. Org Lett. 2018 Jan 5;20(1):256-259. doi: 10.1021/acs.orglett.7b03623. Epub 2017 Dec 19. Org Lett. 2018. PMID: 29256622

3

GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.

Yoo J, Mashalidis EH, Kuk ACY, Yamamoto K, Kaeser B, Ichikawa S, Lee SY. Yoo J, et al. Among authors: yamamoto k. Nat Struct Mol Biol. 2018 Mar;25(3):217-224. doi: 10.1038/s41594-018-0031-y. Epub 2018 Feb 19. Nat Struct Mol Biol. 2018. PMID: 29459785 Free PMC article.

4

Structural requirement of tunicamycin V for MraY inhibition.

Yamamoto K, Katsuyama A, Ichikawa S. Yamamoto K, et al. Bioorg Med Chem. 2019 Apr 15;27(8):1714-1719. doi: 10.1016/j.bmc.2019.02.035. Epub 2019 Mar 2. Bioorg Med Chem. 2019. PMID: 30850266

5

Tunicamycin: chemical synthesis and biosynthesis.

Yamamoto K, Ichikawa S. Yamamoto K, et al. J Antibiot (Tokyo). 2019 Dec;72(12):924-933. doi: 10.1038/s41429-019-0200-1. Epub 2019 Jun 25. J Antibiot (Tokyo). 2019. PMID: 31235901 Review.

6

Synthesis and biological evaluation of a MraY selective analogue of tunicamycins.

Yamamoto K, Sato T, Hikiji Y, Katsuyama A, Matsumaru T, Yakushiji F, Yokota SI, Ichikawa S. Yamamoto K, et al. Nucleosides Nucleotides Nucleic Acids. 2020;39(1-3):349-364. doi: 10.1080/15257770.2019.1649696. Epub 2019 Sep 30. Nucleosides Nucleotides Nucleic Acids. 2020. PMID: 31566068 Free article.

7

Elucidating the Structural Requirement of Uridylpeptide Antibiotics for Antibacterial Activity.

Terasawa Y, Sataka C, Sato T, Yamamoto K, Fukushima Y, Nakajima C, Suzuki Y, Katsuyama A, Matsumaru T, Yakushiji F, Yokota SI, Ichikawa S. Terasawa Y, et al. Among authors: yamamoto k. J Med Chem. 2020 Sep 10;63(17):9803-9827. doi: 10.1021/acs.jmedchem.0c00973. Epub 2020 Aug 17. J Med Chem. 2020. PMID: 32787111

8

Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway.

Konishi H, Isozaki S, Kashima S, Moriichi K, Ichikawa S, Yamamoto K, Yamamura C, Ando K, Ueno N, Akutsu H, Ogawa N, Fujiya M. Konishi H, et al. Among authors: yamamoto k. Sci Rep. 2021 May 26;11(1):11070. doi: 10.1038/s41598-021-90707-4. Sci Rep. 2021. PMID: 34040123 Free PMC article.

9

Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold.

Okamoto K, Ishikawa A, Okawa R, Yamamoto K, Sato T, Yokota SI, Chiba K, Ichikawa S. Okamoto K, et al. Among authors: yamamoto k. Bioorg Med Chem. 2022 Feb 1;55:116556. doi: 10.1016/j.bmc.2021.116556. Epub 2021 Dec 25. Bioorg Med Chem. 2022. PMID: 35016115

10

Corrigendum to "Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold" Bioorganic & Medicinal Chemistry 55 (2021) 116556.

Okamoto K, Ishikawa A, Okawa R, Yamamoto K, Sato T, Yokota SI, Chiba K, Ichikawa S. Okamoto K, et al. Among authors: yamamoto k. Bioorg Med Chem. 2022 May 1;61:116689. doi: 10.1016/j.bmc.2022.116689. Epub 2022 Mar 7. Bioorg Med Chem. 2022. PMID: 35272912 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,265 results

Search Page